Kawaguchi et al. also found that Matteoni type 4 NAFLD is both a genetically and clinically different subset from the other spectra of the disease and that the PNPLA3 variant is strongly associated with the progression of NASH in Japanese patients with NAFLD [89,90]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatohepatitis.